Newsfiscal.ai
Clearmind Medicine Completes Patient Recruitment for First Alcohol Use Disorder Cohort of CMND-100 Phase I/IIa Trial
· Published
Article summary
Clearmind Medicine has finished recruiting patients for the initial segment of Part B of its Phase I/IIa clinical trial for CMND-100, a treatment for Alcohol Use Disorder.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…